Cardiovascular Abnormalities Clinical Trials

Santa Ana : Coastal Multi-Specialty Research

Cardiovascular outcomes study to evaluate the potential to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event & type II diabetes mellitus.

Santa Ana : Coastal Multi-Specialty Research

RESCUE cardiovascular clinical trial

Waterbury : Chase Medical Research, LLC

A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk.

Waterbury : Chase Medical Research, LLC

The Effect of Dulaglutide on Major Cardiovascular Events in Patients with Type 2 Diabetes: Researching Cardiovascular Events with a Weekly Incretin in Diabetes.

Daytona Beach : Cardiology Research Associates

Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome

Fort Lauderdale : Holy Cross Jim Moran Heart and Vascular Research Institute

EXAMINE- This study is to evaluate the cardiovascular outcomes of alogliptin, once daily, compared with placebo, in addition to stand of care, in subjects with Type 2 Diabetes Mellitus and Acute Coronary Syndrome.

Pembroke Pines : University Clinical Research, Inc.

Men and Women ages 18 or older with High Blood Pressure and Diabetes Type 2 who DO NOT require the use of Insulin to control their Diabetes Levels

West Palm Beach : Metabolic Research Institute, Inc.

Previous heart attack or stroke? Cardiovascular disease? Diabetes? Elevated blood sugar levels?

Stockbridge : Clinical Research Atlanta

The Light Study

Wichita : Via Christi Research

Study of TAK-875 in Adults with Type 2 Diabetes & Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Lexington : University of Kentucky Chandler Medical Center

Cardiology & Vascular Diseases: Research Study on Weight Loss and Cardiovascular Disease

Hazelwood : Healthcare Research Network

Do you have Gout and Cardiovascular Disease? Are you a male age 50+ years old or female age 55+ ? If so, you may qualify for our study! Please call us today for more information.

Toms River : Physicians Research Center, LLC

Phase 3, multicenter, randomized, parallel-group, double-blind, placebo-controlled, event-driven study in approximately 11,000 patients with high-risk vascular disease (HRVD).

Bronx : Biomedical Research Alliance of New York

Type 2 Diabetes Mellitus and Cardiovascular Outcomes - Adults

Cincinnati : Cincinnati Children's Hospital Medical Center

Marfan Syndrome (MFS) Medication Study

Dallas : Baylor Research Institute

Evaluation of the clinical performance of the Valiant thoracic Stent Graft with the Captivia Delivery System for the treatment of acute, complicated type B aortic dissections.

San Antonio : Sun Research Institute

COPD with Cardiovascular Disease